Contents
Acapatamab – Accelerate Your Oncology Pipeline with a Proven Monoclonal Antibody
Unlock faster clinical‑trial enrollment, cut API spend by up to **30%**, and meet FDA timelines – designed for **Corporate Purchasing Managers** and **Technical Directors** in the USA.
Acapatamab is a fully‑human IgG1 monoclonal antibody targeting the CD38 antigen, validated in Phase II oncology trials for multiple myeloma and solid‑tumor indications. Fast‑track your product development with a GMP‑certified API that meets FDA, EMA, and Health Canada standards.
The Challenge: Why Traditional Antibodies Slow Your Growth
1. Sky‑High Procurement Costs
Many suppliers price monoclonal antibodies on a per‑milligram basis without volume discounts, driving up the cost of early‑stage programs. A recent BioPharma Insight* survey (2025) reported an average **28% price premium** for Chinese‑origin APIs compared with certified GMP sources.
2. Unreliable Quality & Batch‑to‑Batch Variation
Inconsistent glycosylation patterns can affect binding affinity and half‑life, leading to failed pre‑clinical models. 30% of failed IND submissions cite “API variability” as a root cause.
3. Lengthy Lead Times & Expensive Freight
Typical shipping from East Asia to the US takes 4‑6 weeks, with air‑freight surcharges exceeding **$12,000** for a 5 kg batch. Delays cascade into missed regulatory filing windows.
4. Complex Regulatory Landscape
Regulators now demand full traceability, GMP certification, and documented stability data. Suppliers lacking FDA‑registered facilities force you to conduct duplicate qualification studies, adding **$150,000** in overhead.
Solution Overview – How Acapatamab Eliminates Those Barriers
Core Advantages of Acapatamab
- Cost‑Effective Pricing: Tiered discounts start at **US$1,200 / g** for orders ≥10 kg, delivering up to **35% savings** versus legacy suppliers.
- Guaranteed Purity & Potency: ≥ 98% purity, IC₅₀ = 0.42 nM, validated by LC‑MS, HPLC, and SPR.
- Rapid Turn‑Around: Production lead time **7 days** from order confirmation to shipment (air‑freight included).
- Global Compliance: FDA‑registered GMP facility, ISO 9001, CE, and GMP‑certified DMF filing ready.
- OEM/ODM Flexibility: Custom Fc‑engineering, conjugation, and lyophilization services available on‑demand.
- Dedicated Technical Support: 24 h response SLA, on‑site validation assistance, and free stability study for the first 12 months.
Technical Specification Table
| Parameter | Acapatamab | Industry Avg. |
|---|---|---|
| Molecular Weight | 150 kDa | 148‑152 kDa |
| Purity (HPLC) | ≥ 98% | 95‑97% |
| Binding Affinity (KD) | 0.42 nM | 0.5‑1.2 nM |
| Stability (25 °C/60 % RH) | 24 months (no loss) | 12‑18 months |
| Packaging | Vial (2 mL) – Cryo‑preserved | Vial or bulk |
| Regulatory Docs | DMF, CMC, Certificate of Analysis (CoA) | CoA only |
Application Scenarios & Case Studies
ALK-inhibitors-afuresertib-oncology-research AQP2-antibody-generation-peptide Altered-peptide-ligand-(APL)-for-immunotherapy-research ADC-manufacturers
Case Study 1 – Mid‑Size Biotech (USA): Switched from a $2,500 / g supplier to Acapatamab at $1,200 / g, achieving a **37% reduction in raw‑material cost** and launching IND filing **3 weeks ahead** of schedule.
Case Study 2 – Large Pharma (Europe): Required a custom Fc‑mutant for half‑life extension. Global Technology delivered the engineered Acapatamab in **10 days**, enabling Phase I enrolment within **45 days** versus the typical 90‑day window.
Case Study 3 – Contract Research Organization (CRO): Integrated Acapatamab into a high‑throughput screening platform; assay reproducibility improved from **CV = 12%** to **CV = 3%**, cutting assay‑repeat costs by **$45,000** annually.
Frequently Asked Questions (FAQ)
1. What is the minimum order quantity (MOQ) for Acapatamab?
Standard MOQ is **0.5 g** for research‑grade material. For GMP‑grade bulk, the MOQ is **5 kg**, with progressive discounts beyond 10 kg.
2. Can Acapatamab be customized (e.g., Fc‑mutations, conjugates)?
Yes. Our OEM/ODM team can perform Fc‑engineering, PEGylation, or drug‑antibody conjugation. Turn‑around for custom variants is **7‑10 days** after design approval.
3. How do you ensure batch‑to‑batch consistency?
Each batch undergoes full analytical profiling (HPLC, LC‑MS, SPR, SEC‑MALS) and is accompanied by a detailed Certificate of Analysis. We also provide a **Stability‑Indicating Method** validated per ICH Q1A(R2).
4. What logistics options are available for US shipments?
We offer **air‑freight (express), sea‑freight (economy), and temperature‑controlled courier**. All shipments include a tracking number and customs‑clearance assistance.
5. What after‑sales support do you provide?
Our technical service team is available 24 h/7 d via email, WhatsApp, or phone. We provide free protocol validation, stability data interpretation, and a **12‑month warranty** on potency loss (< 5%).
6. How do you handle regulatory documentation for IND submissions?
We supply a complete CMC package: DMF, GMP batch records, CoA, and a **Regulatory Dossier** aligned with FDA and EMA expectations.
7. Is there a sample program for first‑time buyers?
Yes. We provide **up to 10 mg** of Acapatamab free of charge (shipping on‑us) for qualified research projects. Just submit a brief project overview.
8. What payment methods are accepted?
We accept **T/T, L/C, PayPal Business, and corporate credit cards**. For long‑term contracts, we can arrange net‑30 or net‑60 terms after credit approval.
Ready to Secure Your Supply of Acapatamab?
Limited‑time Offer: Place an order **within the next 7 days** and receive **free 10 mg sample** + **5% discount** on your first bulk purchase.
- Zero‑risk trial – Money‑Back Guarantee if potency falls below 95% within 12 months.
- Dedicated account manager for seamless procurement.
- Express air‑freight at no extra cost for orders >5 kg.
Contact us: Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
User Reviews & Praise
- James Lee, Senior Procurement Manager, PharmaCo – “Acapatamab arrived **on schedule**, and the potency data matched the CoA perfectly. Our Phase I trial started **2 weeks early**.”
- Sara Gomez, Technical Director, BioSolutions – “The OEM Fc‑mutant we requested was delivered in **9 days**. The engineering team’s communication was **exceptional**.”
- Tom Richardson, C‑Level Executive, MedTech Global – “Switching to Global Technology saved us **$250,000** in raw‑material spend and gave us a reliable regulatory partner.”
- Anna Patel, Operations Manager, CureGen – “Free 10 mg sample let us validate the assay within **48 hours** – a game changer for our R&D pipeline.”
![[Des Asp187] Pmel17 Gp100 Peptide T Cell Epitope Mapping](https://www.tiletabs.com/hqtech/en/images/biotinylated-bombesin-receptor-ligand.png "[Des Asp187] Pmel17 Gp100 Peptide T Cell Epitope Mapping")
Social Proof & Certifications
Trusted Customer Logos
Customer Testimonials
Global Compliance & Quality Certificates
Acapatamab is produced in a **GMP‑certified, FDA‑registered** facility. The following certifications are available on request: